Open Insider Trading Activity for Map Pharmaceuticals, Inc. SVP, Chief Business Officer Gianakakos Anastasios
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. MAPP | 2013-01-25 | 2013-01-23 | Map Pharmaceuticals, Inc. | Gianakakos Anastasios | SVP, Chief Business Officer | Sell | 1 | 30,000 | $24.76 | $742,800.00 | 67.67% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. MAPP | 2012-11-05 | 2012-11-01 | Map Pharmaceuticals, Inc. | Gianakakos Anastasios | SVP, Chief Business Officer | Sell | 1 | 5,767 | $15.64 | $90,195.88 | 31.77% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. MAPP | 2012-04-04 | 2012-04-02 | Map Pharmaceuticals, Inc. | Gianakakos Anastasios | SVP, Chief Business Officer | Sell | 1 | 2,500 | $14.38 | $35,950.00 | 16.80% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. MAPP | 2012-03-13 | 2012-03-09 | Map Pharmaceuticals, Inc. | Gianakakos Anastasios | SVP, Chief Business Officer | Sell | 1 | 10,000 | $17.50 | $175,000.00 | 44.67% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. MAPP | 2012-02-07 | 2012-02-06 | Map Pharmaceuticals, Inc. | Gianakakos Anastasios | SVP & Chief Business Officer | Sell | 1 | 10,000 | $15.00 | $150,000.00 | 44.67% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. MAPP | 2012-01-20 | 2012-01-19 | Map Pharmaceuticals, Inc. | Gianakakos Anastasios | SVP & Chief Business Officer | Sell | 1 | 4,471 | $13.88 | $62,057.48 | 32.43% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. MAPP | 2011-12-14 | 2011-12-12 | Map Pharmaceuticals, Inc. | Gianakakos Anastasios | SVP & Chief Bus Officer | Sell | 2 | 1,341.05 | $97.54 | $130,805.44 | 6.71% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. MAPP | 2011-08-03 | 2011-08-01 | Map Pharmaceuticals, Inc. | Gianakakos Anastasios | SVP, Cor & Business Dev | Sell | 1 | 1,500 | $15.26 | $22,890.00 | 13.87% | View Filing |